Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/7470
Title: Guideline to Assess and Manage Disordered Eating/Eating Disorder in Children/Adolescents/Adults with Type 1 Diabetes
Authors: D'Silva, N.
Hendrieckx, C.
Smart, C.
Ward, W.
Hunyh, T.
Davis, A.
Boyd, M.
Fuery, M.
Walker, N.
d'Emden, H.
Issue Date: 2024
Source: Diabetes Research and Clinical Practice, 2024 (209)
Journal Title: Diabetes Research and Clinical Practice
Abstract: Background: The prevalence of Disordered Eating (DE) in the Type 1 diabetes (T1D) is as high as 40%, with 7% of female adolescents having an Eating Disorder (ED). The dual diagnosis confers a significant increase in morbidity and/or mortality. However, a Clinical Guideline on the best treatment approach is lacking and standard ED treatment protocols are ineffective[1]. Aim: To develop a Consensus Guideline to prevent and manage DE/ED in people with T1D across all ages, drawing on published evidence and clinical experience. Method: Current literature was reviewed following a search strategy in EMBASE, CINAHL and PsycInfo databases, using controlled vocabulary and free text search terms. Concepts focused on T1D and DE/ED and limited to English language, published in the last 10 years. An expert panel of clinicians with significant clinical and research experience in ED/DE and diabetes was established, with national representation of the Diabetes Multidisciplinary Team (Endocrinologists, General Paediatrician, Psychiatry specialising in Eating Disorders, Psychology, Dietitian, Credentialed Diabetes Educator) and consumers. The panel reached a consensus based on their clinical experience and literature search. Extensive peer review, consumer engagement/review was undertaken. Results: The Guideline was completed in August 2022 and presented at National Conferences (Australian Diabetes Society 2021, Australasian Paediatric Endocrine Group 2022, Australian Paediatric Society-International Society for Paediatric and Adolescent Diabetes 2022). It has been endorsed and published (Clinical Excellence Queensland and Australia New Zealand Paediatric Endocrinology and Diabetes Society in 2022). Conclusion: With this Guideline, there is now a document with a systematic approach to provide meaningful care that can be adapted locally. The Guideline has received much interest, is endorsed and published in Australia. It is seeking greater awareness globally.
DOI: 10.1016/j.diabres.2024.111463
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L2031309726&from=export
http://dx.doi.org/10.1016/j.diabres.2024.111463
Type: Conference Abstract
Appears in Sites:Children's Health Queensland Publications
Queensland Health Publications

Show full item record

Page view(s)

28
checked on Jun 24, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.